Related Experiment Video
Updated: Jan 26, 2026

Evaluation of the Spatial Distribution of γH2AX following Ionizing Radiation
Published on: August 7, 2010
Protective effect of the antioxidative peptide SS31 on ionizing radiation-induced hematopoietic system damage in mice
Xiaoliang Han1, Ping Gao1, Ying Zhang1
1Affiliated Hospital North China University of Science and Technology, Tangshan, Hebei, China, 063000.
Abstract:
Ionizing radiation (IR) causes severe damage to the hematopoietic system; thus, it is necessary to explore agents or compounds that can reduce this damage. SS31 is a mitochondria-targeted peptide that can scavenge cellular reactive oxygen species (ROS) and inhibit the production of mitochondrial ROS. Therefore, in this study, we discuss the protective effect of SS31 on IR-induced hematopoietic system damage. Our results showed that treatment with 6 mg/kg SS31 elevated the survival rate of lethally irradiated mice and increased the numbers of white blood cells, red blood cells, hemoglobin and platelets in mice exposed to 4 Gy whole-body irradiation. In addition, SS31 administration improved the number of hematopoietic stem/progenitor cells (HSPCs) and the self-renewal and reconstitution abilities of these cells in irradiated mice. The elevation of ROS levels is the main cause of IR-induced hematopoietic system damage, and SS31 can effectively reduce the ROS level in HSPCs. The above results suggest that SS31 can protect the hematopoietic system from radiation-induced damage by reducing cellular ROS levels.
Insights
The peptide SS31 protects the hematopoietic system from ionizing radiation (IR) damage by reducing reactive oxygen species (ROS). This study shows SS31 improves survival and blood cell counts in irradiated mice.
Area of Science:
- Hematology
- Radiation Biology
- Mitochondrial Medicine
Background:
- Ionizing radiation (IR) poses a significant threat to the hematopoietic system.
- Reactive oxygen species (ROS) play a critical role in IR-induced damage.
- Developing radioprotective agents is crucial for mitigating radiation-related injuries.
Purpose of the Study:
- To investigate the protective effects of the mitochondria-targeted peptide SS31 against IR-induced damage to the hematopoietic system.
- To evaluate SS31's impact on survival rates, blood cell counts, and hematopoietic stem/progenitor cell (HSPC) function post-irradiation.
Main Methods:
- Mice were exposed to lethal whole-body irradiation (4 Gy).
- SS31 treatment (6 mg/kg) was administered to assess its protective efficacy.
- Hematopoietic parameters, including blood cell counts and HSPC function, were analyzed.
Main Results:
- SS31 treatment significantly increased the survival rate of lethally irradiated mice.
- SS31 administration restored white blood cells, red blood cells, hemoglobin, and platelet levels.
- SS31 improved HSPC numbers, self-renewal, and reconstitution abilities, while reducing ROS levels in HSPCs.
Conclusions:
- SS31 demonstrates significant radioprotective effects on the hematopoietic system.
- The mechanism of protection involves the scavenging of ROS and inhibition of mitochondrial ROS production.
- SS31 is a promising therapeutic candidate for mitigating radiation-induced hematopoietic damage.
More Related Videos
06:21Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Related Concept Videos
Biological Effects of Radiation
Ionization Energy
Peptide Bonds
Radiation: Applications
The average...
Absorption of Radiation
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...